Can May-Thurner syndrome cause large menstrual clots?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

May-Thurner Syndrome Does Not Directly Cause Large Menstrual Clots

May-Thurner syndrome (MTS) itself does not cause large menstrual clots, but the anticoagulation therapy required to treat MTS-related deep vein thrombosis can significantly worsen menstrual bleeding and lead to large clots.

Understanding the Mechanism

MTS is a vascular compression syndrome where the right common iliac artery compresses the left common iliac vein, leading to venous hypertension and increased risk of deep vein thrombosis (DVT) in the left lower extremity 1, 2. The syndrome primarily manifests as:

  • Lower extremity DVT (65% of cases)
  • Lower limb edema (54% of cases)
  • Varicose veins
  • Chronic venous insufficiency
  • Pelvic congestion syndrome 3, 4

The critical distinction is that MTS causes pelvic and lower extremity venous problems, not uterine or menstrual dysfunction directly.

The Anticoagulation Connection

When MTS causes DVT, patients require anticoagulation therapy (such as rivaroxaban, apixaban, or warfarin) 2. This anticoagulation is what leads to heavy menstrual bleeding (HMB) and large menstrual clots, not the MTS itself 5.

Patients on anticoagulation for venous thromboembolism experience:

  • Increased menstrual blood loss
  • Large clot passage
  • Iron deficiency anemia
  • Impaired quality of life
  • Risk of recurrent VTE if anticoagulation is stopped 5

Clinical Approach

If a patient presents with both MTS and large menstrual clots:

  1. Recognize this as anticoagulation-related gynecologic bleeding, requiring multidisciplinary management 5

  2. Acute management should involve:

    • Gynecology for hormonal therapies (combined hormonal contraceptives are NOT contraindicated despite common misconceptions) 5
    • Hematology/thrombosis specialist for anticoagulation optimization
    • Consider tranexamic acid
    • Iron supplementation or infusion for anemia 5
  3. Long-term strategies include:

    • Switching anticoagulants
    • Dose reduction for extended prophylaxis (e.g., rivaroxaban 10 mg daily instead of 20 mg) 5
    • Hormonal therapies
    • Endometrial ablation for completed fertility 5

Common Pitfall to Avoid:

Do not attribute menstrual symptoms directly to MTS anatomy. The pelvic venous congestion from MTS affects pelvic veins and lower extremities, not the endometrium or menstrual flow. If large menstrual clots are present, investigate anticoagulation use, bleeding disorders, or structural uterine pathology—not the iliac vein compression itself.

When MTS Might Indirectly Relate to Pelvic Symptoms

MTS can cause pelvic congestion syndrome with chronic pelvic pain 4, but this presents as:

  • Chronic pelvic pain (not cyclical menstrual pain)
  • Pelvic venous varicosities
  • Dyspareunia
  • Not as altered menstrual bleeding patterns

The presence of large menstrual clots in an MTS patient should trigger evaluation for anticoagulation-related bleeding or other gynecologic pathology (fibroids, polyps, adenomyosis, hyperplasia), not attribution to the venous compression itself.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.